HOXA9 is required for survival in human MLL-rearranged acute leukemias
Blood , Volume 113 - Issue 11 p. 2375- 2385
Leukemias that harbor translocations involving the mixed lineage leukemia gene (MLL) possess unique biologic characteristics and often have an unfavorable prognosis. Gene expression analyses demonstrate a distinct profile for MLL-rearranged leukemias with consistent high-level expression of select Homeobox genes, including HOXA9. Here, we investigated the effects of HOXA9 suppression in MLL- rearranged and MLL-germline leukemias using RNA interference. Gene expression profiling after HOXA9 suppression demonstrated co-down-regulation of a program highly expressed in human MLL- AMLand murine MLL-leukemia stem cells, including HOXA10, MEIS1, PBX3, and MEF2C. We demonstrate that HOXA9 depletion in 17 human AML/ALL cell lines (7 MLL-rearranged, 10 MLL-germline) induces proliferation arrest and apoptosis specifically in MLL-rearranged cells (P = .007). Similarly, assessment of primary AMLs demonstrated that HOXA9 suppression induces apoptosis to a greater extent in MLL-rearranged samples (P = .01). Moreover, mice transplanted with HOXA9-depleted t(4;11) SEMK2 cells revealed a significantly lower leukemia burden, thus identifying a role for HOXA9 in leukemia survival in vivo. Our data indicate an important role for HOXA9 in human MLL-rearranged leukemias and suggest that targeting HOXA9 or downstream programs may be a novel therapeutic option. © 2009 by The American Society of Hematology.
|, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Faber, J, Krivtsov, A.V, Stubbs, M.C, Wright, R, Davis, T.N, van den Heuvel-Eibrink, M.M, … Armstrong, S.A. (2009). HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood, 113(11), 2375–2385. doi:10.1182/blood-2007-09-113597